| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Department of Biomedical Sciences, Center for Biotechnology Development and Biodiversity Research, Division of Biochemistry, University of Sassari, Sassari, Italy; and the National Laboratory of the National Institute of Biostructures and Biosystems, Osilo, Italy.
Correspondence to Carlo Ventura, MD, PhD, Department of Biomedical Sciences, Division of Biochemistry, University of Sassari, Viale San Pietro 43/B, 07100 Sassari, Italy. E-mail cvent{at}libero.it
The prodynorphin gene and its product, dynorphin B, have been found to promote cardiogenesis in embryonic cells by inducing the expression of GATA-4 and Nkx-2.5, two transcription factorencoding genes essential for cardiogenesis. The molecular mechanism(s) underlying endorphin-induced cardiogenesis remain unknown. In the present study, we found that GTR1 embryonic stem (ES) cells expressed cell surface
opioid receptors, as well as protein kinase C (PKC)-
, -ß1, -ß2, -
, -
, and -
. Cardiac differentiation was associated with a marked increase in the Bmax value for a selective opioid receptor ligand and complex subcellular redistribution of selected PKC isozymes. PKC-
, -ß1, -ß2, -
, and -
all increased in the nucleus of ES-derived cardiac myocytes, compared with nuclei from undifferentiated cells. In both groups of cells, PKC-
and -
were mainly expressed at the nuclear level. The nuclear increase of PKC-
, -ß1, and -ß2 was due to a translocation from the cytosolic compartment. In contrast, the increase of both PKC-
and PKC-
in the nucleus of ES-derived cardiomyocytes occurred independently of enzyme translocation, suggesting changes in isozyme turnover and/or gene expression during cardiogenesis. No change in PKC-
expression was observed during cardiac differentiation. Opioid receptor antagonists prevented the nuclear increase of PKC-
, PKC-ß1, and PKC-ß2 and reduced cardiomyocyte yield but failed to affect the nuclear increase in PKC-
and -
. PKC inhibitors prevented the expression of cardiogenic genes and dynorphin B in ES cells and abolished their development into beating cardiomyocytes.
Key Words: protein kinase C cardiac differentiation embryonic stem cells gene expression endorphins
This article has been cited by other articles:
![]() |
R. N. Re and J. L. Cook The physiological basis of intracrine stem cell regulation Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H447 - H453. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ventura, S. Cantoni, F. Bianchi, V. Lionetti, C. Cavallini, I. Scarlata, L. Foroni, M. Maioli, L. Bonsi, F. Alviano, et al. Hyaluronan Mixed Esters of Butyric and Retinoic Acid Drive Cardiac and Endothelial Fate in Term Placenta Human Mesenchymal Stem Cells and Enhance Cardiac Repair in Infarcted Rat Hearts J. Biol. Chem., May 11, 2007; 282(19): 14243 - 14252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim, A. L. Clark, A. Kiss, J. W. Hahn, R. Wesselschmidt, C. J. Coscia, and M. M. Belcheva {micro}- and {kappa}-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors J. Biol. Chem., November 3, 2006; 281(44): 33749 - 33760. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, P. Paradis, A. Aries, H. Komati, C. Lefebvre, H. Wang, and M. Nemer Convergence of Protein Kinase C and JAK-STAT Signaling on Transcription Factor GATA-4 Mol. Cell. Biol., November 15, 2005; 25(22): 9829 - 9844. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ventura CAM and Cell Fate Targeting: Molecular and Energetic Insights into Cell Growth and Differentiation Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 277 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pepe, O. W.V van den Brink, E. G Lakatta, and R.-P. Xiao Cross-talk of opioid peptide receptor and {beta}-adrenergic receptor signalling in the heart Cardiovasc Res, August 15, 2004; 63(3): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ventura, M. Maioli, Y. Asara, D. Santoni, I. Scarlata, S. Cantoni, and A. Perbellini Butyric and Retinoic Mixed Ester of Hyaluronan: A NOVEL DIFFERENTIATING GLYCOCONJUGATE AFFORDING A HIGH THROUGHPUT OF CARDIOGENESIS IN EMBRYONIC STEM CELLS J. Biol. Chem., May 28, 2004; 279(22): 23574 - 23579. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dell'Era, R. Ronca, L. Coco, S. Nicoli, M. Metra, and M. Presta Fibroblast Growth Factor Receptor-1 Is Essential for In Vitro Cardiomyocyte Development Circ. Res., September 5, 2003; 93(5): 414 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ventura, E. Zinellu, E. Maninchedda, and M. Maioli Dynorphin B Is an Agonist of Nuclear Opioid Receptors Coupling Nuclear Protein Kinase C Activation to the Transcription of Cardiogenic Genes in GTR1 Embryonic Stem Cells Circ. Res., April 4, 2003; 92(6): 623 - 629. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |